About this event

  • Date and time Thu 24 Mar 2022 from 6:00pm to 7:50pm
  • Location Online
  • Organised by Critical Care Medicine

This session will provide an extensive overview and updates on diagnosing and treating delirium. World leaders in the field of delirium in critical illness will provide a bespoke overview of this significantly challenging area for clinicians, patients and relatives. In the most recent research prioritisation exercise, agitation and delirium was ranked amongst the top three challenges for further research.

During this session you will:

  • Advance your knowledge in novel diagnostic techniques including EEG 
  • Understand the challenges in detecting delirium in mechanically ventilated patients
  • Critical appraisal of available evidence in prevention and treatment of delirium 
  • Establish the risks and benefits of pharmacological versus non-pharmacological therapies and explore the role of Alpha-2 agonists 
  • Develop awareness of novel conceptions in delirium management

This live stream has CPD accreditation.

Join in the conversation online by using #RSMLive 
Follow us on Twitter: @RoySocMed

Registration for this live stream will close 2 hours prior to the start time. You will receive the link 2 hours before the meeting. Late registrations will not be accepted.

Key speakers

Tim Walsh

Professor Tim Walsh

Chair of Critical Care, University of Edinburgh

Speaker's biography

Professor Tim Walsh is Director of Research & Innovation for NHS Lothian, and Health Innovation South East Scotland. He is also Professor of Critical Care at the University of Edinburgh and Honorary Consultant in Critical Care at Edinburgh Royal Infirmary. He is Head of the Academic Dept of Anaesthesia, Critical Care, and Pain Medicine in the University of Edinburgh, and Co-director of Acute Care Edinburgh a multidisciplinary research grouping in the University of Edinburgh Usher Institute. Tim leads a multidisciplinary clinical research group with interests including transfusion medicine, sedation in the critically ill, recovery from critical illness and the epidemiology and prevention of ICU acquired infection. He has a particular interest in large pragmatic clinical trials, complex health intervention trials, and the evaluation of novel diagnostics and technologies in acute care. He is a past Chairman of the NIHR UK Critical Care Research Network and UK Critical Care Research Group.

Arjen Slooter

Professor Arjen Slooter

Professor of Intensive Care Neuropsychiatry, University Medical Centre Utrecht

Speaker's biography

Arjen Slooter studied Medicine at the Vrije Universiteit, Amsterdam (1994) and was research fellow in Neuro-Epidemiology at the G.H. Sergievsky Center, Columbia University, New York (1996). He received a PhD in Epidemiology from Erasmus University, Rotterdam (1998), on a thesis on dementia. During his residency in Neurology at UMC Utrecht (1999-2004), he became enthusiastic for Neurocritical Care. After a fellowship in Intensive Care Medicine (AMC Amsterdam, 2004-2006), he rejoined the UMC Utrecht where he is currently working as consultant neurologist-intensivist at the Department of Intensive Care Medicine. In 2016, he was appointed as Professor in Intensive Care Neuropsychiatry at Utrecht University. Dr Slooter has been chair of the delirium section of the (American) Society of Critical Care Medicine (SCCM) guidelines on pain, agitation/sedation, delirium, immobility, and sleep disruption. In addition, he is President of the European Delirium Association and initiator and chair of an international consortium to update nomenclature on delirium and acute encephalopathy. Dr Slooter has an honorary appointment at UZ Brussel and Vrije Universiteit Brussels. The research focus of Arjen Slooter is on delirium and on neuropsychiatric outcome after anaesthesia/surgery or critical illness. Using various methods and approaches (epidemiology, EEG, MRI), he has investigated all aspects of delirium, including its phenomenology and brain network characteristics, detection and monitoring, risk factors, prognosis, prevention and treatment. Research on neuropsychiatric outcomes includes risk factor analysis on cognitive decline, mental illness and chronic pain after critical illness and treatment in the ICU. The clinical focus of Arjen Slooter is on Intensive Care of neurological- and neurosurgical patients, and on neurological complications of critical illness. Arjen lives with his wife Barbara, daughter Pien (2001) and son Bas (2004) in beautiful Utrecht.


View the programme

Welcome and introduction

Dr Cathy McKenzie Honorary Reader in Clinical Therapeutics and Critical Care Senior Pharmacist, King’s Health Partners, King’s College London

A practical approach to treatment delirium in critical illness

Professor Tim Walsh, Professor of Critical Care Medicine, University of Edinburgh

Questions and answers
Novel advances in delirium

Professor Arjen Slooter, Professor of Intensive Care Neuropsychiatry, University Medical Centre Utrecht

Questions and answers
Close of meeting



Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM. 

Registration for this live stream will close 2 hours prior to the start time. You will receive the live stream link 2 hours before the meeting. Late registrations will not be accepted.

Live stream recordings will be available for registered delegates up to 60 days after the live event, via Zoom. The link will be sent 24 hours after the live stream takes place.  

This live stream will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.

Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member